Harmonizing Innovation and Regulation: Swiss Health Insurance
Navigates Digital Health Technologies for Enhanced Patient
Engagement
Estelle Pfitzer
1,5 a
, Birte Jörn
2
and Tobias Kowatsch
1,3,4 b
1
School of Medicine, Universität St. Gallen, St. Gallen, Switzerland
2
Corporate Venture and Innovation, Sanitas, Zürich, Switzerland
3
Institute for Implementation Science in Health Care, University of Zurich, Zurich, Switzerland
4
Department of Management, Technology, and Economics, ETH Zurich, Zurich, Switzerland
5
MTIP Ag, Basel, Switzerland
Keywords: Digital Health Technologies, Health Insurance, Care Support, Health and Wellness.
Abstract: We investigate the innovative domain of digital health technologies (DHTs) within the unique and highly
regulated context of the Swiss health insurance system, focusing on the pragmatic approach adopted by
Sanitas, a leading health insurance provider in Switzerland. Drawing on an insightful interaction with Birte
Jörn, manager for innovation and venturing at Sanitas, the following position statement underlines the
strategic integration and adoption of DHTs to enhance customer engagement, reinforce patient self-
management, and, subsequently, mitigate healthcare and insurance service costs. Among barriers such as
rigorous regulations and reimbursement limitations, insights collected from various DHT pilot programs
unveil certain tendencies, like notable customer interest in DHTs oriented towards lifestyle, mental well-
being, and chronic disease management.
1 INTRODUCTION
The Swiss health insurance system represents a
unique model that combines universal coverage with
a regulated competitive market. Rooted in ensuring
healthcare access for all, every resident living in
Switzerland for more than 3 months must have basic
insurance coverage (Obligatorische
Krankenversicherung, 2022.). This coverage is
standardized, offering essential health services to
everyone, irrespective of their socio-economic status
(Marks-Sultan et al., 2016). The Swiss healthcare
system operates in a highly decentralized manner,
each of the 26 cantons has distinct health legislations
and plays a crucial role in healthcare provision, from
emergency services to hospital planning, and is a
significant source of public financing (Maurer et al.,
2022).
In this context of a regulated competitive market,
digital health technologies (DHTs) emerge as a
a
https://orcid.org/0009-0006-0577-2757
b
https://orcid.org/0000-0001-5939-4145
promising avenue for health insurance providers in
Switzerland to differentiate themselves. By
leveraging DHTs, such as clinical information
systems, digital preventive care interventions, patient
monitoring services, care support technologies,
digital diagnostics, or digital therapeutics, insurers
can enhance patient engagement and potentially
reduce healthcare costs.
For instance, a chronic disease management
platform can empower patients to manage their
conditions more effectively, reducing the need for
frequent doctor or hospital visits (Jacobson et al.,
2023; Kowatsch & Fleisch, 2021; Kvedar et al., 2014;
Wang et al., 2023). When integrated into the broader
healthcare ecosystem, such DHT can improve patient
outcomes and create a more sustainable healthcare
system (Benis et al., 2021; Digital Implementation
Investment Guide (DIIG): Integrating Digital
Interventions into Health Programmes, n.d.). It is
difficult to calculate long-term cost implications of
digital health technologies when incorporating broad
Pfitzer, E., Jörn, B. and Kowatsch, T.
Harmonizing Innovation and Regulation: Swiss Health Insurance Navigates Digital Health Technologies for Enhanced Patient Engagement.
DOI: 10.5220/0012368300003657
Paper published under CC license (CC BY-NC-ND 4.0)
In Proceedings of the 17th International Joint Conference on Biomedical Engineering Systems and Technologies (BIOSTEC 2024) - Volume 2, pages 833-837
ISBN: 978-989-758-688-0; ISSN: 2184-4305
Proceedings Copyright © 2024 by SCITEPRESS – Science and Technology Publications, Lda.
833
considerations, such as costs of the technology
lifecycle and those to integrate technology into the
clinical workflow (Mathews et al., 2019). However,
in their literature review assessing the cost-
effectiveness of digital health interventions, Gentili et
al. found that 32 out of 35 studies demonstrated gains
in Quality-Adjusted Life Years (QALYs), with most
also reporting notable cost savings (Gentili et al.,
2022a).
Figure 1: Average Monthly Healthcare Expenditure per
Swiss Household (Household Expenditure | Federal
Statistical Office, n.d.).
The increase in healthcare costs per household is
evident when comparing data from 2010 to 2020, as
depicted in Figure 1. During this decade, households
experienced a rise of more than 100 CHF per month
in their healthcare expenditures. Interestingly,
expenses associated with supplementary health
insurance remained relatively stable throughout these
years. Conversely, other healthcare costs
encompassing medication, dental services, and
laboratory analyses have seen a decline. The primary
contributor to the escalation in expenses is the
obligatory health insurance, which has shown a
pronounced uptick. This trend emphasises the
importance of leveraging DHT to mitigate healthcare
expenses (Gentili et al., 2022b).
Sanitas, founded in 1956, is one of Switzerland's
leading health insurance companies covering basic
and supplementary health insurance. To gain insight
into the perspective of Swiss health insurers regarding
digital health, this position paper outlines the results
of a conversation with Birte Jörn, manager for
innovation and venturing at Sanitas. Questions
focused on Sanitas' implementation of DHTs,
specifically whether they are utilized for prevention
or disease management, and if these were developed
internally or through external collaborations. The
conversation also touched upon the strategic aims of
deploying DHTs, including revenue generation, cost-
efficiency, and customer loyalty. Additionally, we
explored Sanitas' experiences and outcomes with
various DHTs, seeking insights into their relative
effectiveness and areas for improvement.
2 POSITIONING STATEMENT
DHTs encompass various technologies and
methodologies to improve healthcare delivery,
outcomes, and personal wellness. While it primarily
serves patients, DHTs also help a wide array of other
stakeholders in the healthcare sector, like healthcare
professionals and hospital administrations, with
operational and clinical software systems (Keasberry
et al., 2017). For patients, DHTs can be broadly
classified into five main categories. The first category
is health and wellness solutions, designed to promote
overall well-being and proactive health maintenance
(Thai et al., 2023). These DHTs are complemented by
the second category, patient monitoring technologies,
emphasizing real-time health metrics tracking (Le
Goff-Pronost & Bongiovanni-Delarozière, 2023).
Third, care-supporting technologies facilitate disease
management and self-management. Furthermore,
digital diagnostics harness technology for early
detection and diagnosis of diseases, ensuring timely
treatment (Parikh & Helmchen, 2022; Vasudevan et
al., 2022). Finally, digital therapeutics offer
technologically driven treatment to directly address
health concerns (Jacobson et al., 2023; Wang et al.,
2023).
Sanitas has not developed or is directly offering
any DHTs with clear medical purpose and relevant
medical certification. Since, as an insurance
company, they cannot prescribe medication.
However, more lifestyle-oriented applications in the
category health and wellness for prevention are of
great interest to health insurers but also the most
challenging area due to very limited possibilities for
reimbursement. It is also difficult to reach and engage
the low socioeconomic status population with
preventive solutions, although they suffer from the
most non-communicable diseases and would benefit
from these lifestyle DHT solutions the most
(Kowatsch et al., 2019).
8.5%
9.0%
9.5%
10.0%
10.5%
11.0%
11.5%
0
100
200
300
400
500
600
700
800
2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Portion of revenue spent on Healthcare
Average Monthly Healthcare Expenditure (CHF)
Obligatory Health Insurance
Supplementory Health Insurance
O the r H ealt hca re Cost s
Portion of revenue spent on Heal thcare
Scale-IT-up 2024 - Workshop on Emerging Business Models in Digital Health
834
While medical doctors mainly oversee disease
management, Sanitas employs a deliberate strategy to
engage with DHTs and enhance customer experience
and offers solutions covering different categories:
1. Non-Health system software solution:
Sanitas provides a portal accessible via a web
browser or mobile application, enabling
customers to manage their insurance details
autonomously. The Sanitas Portal offers a
comprehensive coverage view, facilitates
reclaim voucher scanning, and highlights
exclusive health offers. The mobile application
won second place at the Best of Swiss App
Awards 2022 in both “Business Impact” and
“User Experience & Usability”.
2. Care Support: The insurance as developed its
own mobile applications for care support. They
are not classified as medical devices, like one
featuring a "health navigator,” to disseminate
valuable health-related information. Through a
strategic partnership with Medgate, a leading
telemedicine provider specializing in remote
consultations and digital health services,
customers can address medical inquiries using a
digital assistant and directly access Medgate
doctors for teleconsultations or appointment
bookings via the Sanitas Medgate app.
3. Health and Wellness: Sanitas offers a white-
labelled app for individuals managing chronic
conditions. The Sanitas Digital Health Coach
addresses widespread issues such as stress and
unhealthy living, which can culminate in
conditions like high blood pressure and type 2
diabetes. The interactive platform enables users
to evaluate vital health metrics, such as heart age
and diabetes risk, through self-tests but also
ensures meticulous tracking of key health
parameters like blood pressure and sleep data via
a health diary. Furthermore, the coach provides
actionable and medically substantiated
recommendations, aiding users in navigating
their health data toward actual health
improvements. Coupled with timely reminders
for medications and health measurements, the
Sanitas Coach promotes a sustainable transition
towards healthier living.
4. Recommendations on DHTs: In addition to the
above, Sanitas gives recommendations and links
to other DHTs for specific customer journeys,
guiding clients toward beneficial digital
resources. In collaboration with leading DHT
startups, Sanitas suggests the following:
- Aepsy: A Swiss platform connecting users
with selected psychotherapists through
online chat, video telephony, or in-person
meetings.
- Pathmate Technologies: An online
platform designed for individuals with
chronic diseases, offering personalized
healthcare management and coaching.
- TOM: A mobile application that provides
medication reminders to assist users in
maintaining consistent medication
regimens.
- Pregnolia: A company that has developed
a technique to predict the risk of premature
birth. Notably, Sanitas is the first health
insurer in Switzerland to cover the
Pregnolia test for those with
supplementary outpatient insurance (Stone
& House, 2023).
2.1 Strategic Objectives
As DHTs evolve, Sanitas pursues a strategy that
aligns with multiple, well-defined goals. Firstly, the
company aims to enhance customer loyalty by
delivering pertinent and engaging offerings. This
involves providing digital tools that empower patients
to actively manage their health (Iglesias et al., 2018).
This strategy fosters self-management and can reduce
overall medical costs (Awad et al., 2021).
Additionally, a calculated shift towards a self-service
model for insurance-related queries and processes
supports Sanitas' approach. This move enhances
customer convenience by simplifying interactions
and reducing costs related to insurance services.
Overall, offering DHTs enhances the appeal of health
insurance for patients, enabling them to manage their
health and potentially lower their medical costs and
health insurance expenses.
2.2 Challenges and Insights
Exploring the deployment of DHTs presents
challenges and insights for Sanitas. Significant
barriers have surfaced through various pilots of
DHTs. The main challenges identified are limited
reimbursement options and targeted customer
engagement (Reinhardt, 2004). Despite access to
extensive customer data, strict sector regulations
significantly limit targeting opportunities within the
customer base.
While deriving a one-size-fits-all success pattern
is complex due to variables like usability, customer
age, and cost, certain tendencies emerge. For
Harmonizing Innovation and Regulation: Swiss Health Insurance Navigates Digital Health Technologies for Enhanced Patient Engagement
835
instance, DHTs aiming at prevention, health, and
well-being, such as general fitness or mental well-
being applications, show the highest Sanitas customer
interest. It is also observed that DHTs for chronic
patients, e.g., medication adherence apps, generate
big interest, especially when integrated into a frame
program (overarching healthcare management and
support strategy) by the insurance company. This
underscores that embedding DHTs within a well-
orchestrated, structured program enhances patient
utilization, amplifying its viability and impact.
3 CONCLUSION
Navigating the challenging path of DHT
implementation, Sanitas combines strategic adoption
with encountered hurdles and important insights
within the strictly regulated Swiss health insurance
framework. The journey clearly shows DHTs’ vital
role in increasing customer loyalty, helping efficient
disease self-management, and potentially reducing
costs while being influenced by various impactful
variables like usability and customer demographics.
The balance between technological progress and
regulatory and operational alignment emerges as
crucial, paving the way for synergistic advancements
in patient outcomes and operational efficacy within
the structured competitive market. Future
explorations may focus on ensuring that regulatory
frameworks are flexible and evolving to foster the
development and integration of emerging DHT
pertinent to health insurances, technological
improvements like increasing interoperability among
different health care stakeholders, and forming
strategic alliances with promising DHT companies.
DHT hold significant potential for reducing
healthcare costs, benefiting health insurance
providers. However, a standardized metric for
evaluating cost-effectiveness is essential and still
needed to identify the most financially impactful
solutions within the Swiss healthcare system.
4 CONFLICT OF INTEREST
EP and TK are affiliated with the Centre for Digital
Health Interventions (CDHI), a joint initiative of the
Institute for Implementation Science in Health Care,
University of Zurich, the Department of
Management, Technology, and Economics at ETH
Zurich, and the Institute of Technology Management
and School of Medicine at the University of St.
Gallen. CDHI is funded in part by CSS, a Swiss
health insurer, the Swiss growth-stage investor MTIP,
and the Austrian health provider Mavie Next. TK is
also a co-founder of Pathmate Technologies, a
university spin-off company that creates and delivers
digital clinical pathways. However, CSS, Mavie
Next, or Pathmate Technologies were not involved in
this research. EP works at MTIP, a Swiss healthtech
growth equity firm that helps founders scale up
successful and sustainable digital health businesses.
REFERENCES
Awad, A., Trenfield, S. J., Pollard, T. D., Ong, J. J.,
Elbadawi, M., McCoubrey, L. E., Goyanes, A.,
Gaisford, S., & Basit, A. W. (2021). Connected
healthcare: Improving patient care using digital health
technologies. Advanced Drug Delivery Reviews, 178,
113958. https://doi.org/10.1016/J.ADDR.2021.113958
Benis, A., Tamburis, O., Chronaki, C., & Moen, A. (2021).
One Digital Health: A Unified Framework for Future
Health Ecosystems. J Med Internet Res 2021;
23(2):E22189 Https://Www.Jmir.Org/2021/2/E22189,
23(2), e22189. https://doi.org/10.2196/22189
Digital implementation investment guide (DIIG):
integrating digital interventions into health
programmes. (n.d.).
Gentili, A., Failla, G., Melnyk, A., Puleo, V., Tanna, G. L.
Di, Ricciardi, W., & Cascini, F. (2022a). The cost-
effectiveness of digital health interventions: A
systematic review of the literature. Frontiers in Public
Health, 10. https://doi.org/10.3389/FPUBH.2022.787
135
Gentili, A., Failla, G., Melnyk, A., Puleo, V., Tanna, G. L.
Di, Ricciardi, W., & Cascini, F. (2022b). The cost-
effectiveness of digital health interventions: A
systematic review of the literature. Frontiers in Public
Health, 10. https://doi.org/10.3389/FPUBH.2022.7871
35
Household expenditure | Federal Statistical Office. (n.d.).
Retrieved October 18, 2023, from https://www.bfs.ad
min.ch/bfs/en/home/statistics/economic-social-situatio
n-population/income-consumption-wealth/household-
budget/household-expenditure.html
Iglesias, O., Markovic, S., Bagherzadeh, M., & Singh, J. J.
(2018). Co-creation: A Key Link Between Corporate
Social Responsibility, Customer Trust, and Customer
Loyalty. Journal of Business Ethics 2018 163:1,
163(1), 151–166. https://doi.org/10.1007/S10551-018-
4015-Y
Jacobson, N., Kowatsch, T., & Marsch, L. (2023). Digital
Therapeutics for Mental Health and Addiction: The
State of the Science and Vision for the Future.
Academic Press. https://www.alexandria.unisg.ch/
handle/20.500.14171/107854
Keasberry, J., Scott, I. A., Sullivan, C., Staib, A., & Ashby,
R. (2017). Going digital: a narrative overview of the
Scale-IT-up 2024 - Workshop on Emerging Business Models in Digital Health
836
clinical and organisational impacts of eHealth
technologies in hospital practice. Australian Health
Review, 41(6), 646–664. https://doi.org/10.1071/AH
16233
Kowatsch, T., & Fleisch, E. (2021). Digital Health
Interventions. Connected Business: Create Value in a
Networked Economy, 71–95. https://doi.org/10.1007/
978-3-030-76897-3_4/COVER
Kowatsch, T., Ford, J. G., Howerton, M. W., Lai, G. Y.,
Gary, T. L., Bolen, S., Gibbons, M. C., & Baffi, J.
(n.d.). How to Lower Socioeconomic Inequalities in
Health with Digital Therapeutics? Healthification-A
Short Animation. https://doi.org/10.3389/fcell.2019.0
0074
Kvedar, J., Coye, M. J., & Everett, W. (2014). Connected
health: a review of technologies and strategies to
improve patient care with telemedicine and telehealth.
Health Affairs (Project Hope), 33(2), 194–199.
https://doi.org/10.1377/HLTHAFF.2013.0992
Le Goff-Pronost, M., & Bongiovanni-Delarozière, I.
(2023). Economic evaluation of remote patient
monitoring and organizational analysis according to
patient involvement: a scoping review. International
Journal of Technology Assessment in Health Care,
39(1), e59. https://doi.org/10.1017/S02664623230025
81
Marks-Sultan, G., Kurt, S., Leyvraz, D., & Sprumont, D.
(2016). The legal and ethical aspects of the right to
health of migrants in Switzerland. Public Health
Reviews, 37(1), 1–16. https://doi.org/10.1186/S40985-
016-0027-2/METRICS
Mathews, S. C., McShea, M. J., Hanley, C. L., Ravitz, A.,
Labrique, A. B., & Cohen, A. B. (2019). Digital health:
a path to validation. Npj Digital Medicine 2019 2:1,
2(1), 1–9. https://doi.org/10.1038/s41746-019-0111-3
Maurer, M., Wieser, S., Kohler, A., & Thommen, C.
(2022). Sustainability and Resilience in the Swiss
Health System SWITZERLAND. www.phssr.org
Obligatorische Krankenversicherung Individuelle
Prämienverbilligung. (n.d.).
Parikh, R. B., & Helmchen, L. A. (2022). Paying for
artificial intelligence in medicine. Npj Digital Medicine
2022 5:1, 5(1), 1–5. https://doi.org/10.1038/s41746-
022-00609-6
Reinhardt, U. E. (2004). The Swiss Health System:
Regulated Competition Without Managed Care. JAMA,
292(10), 1227–1231. https://doi.org/10.1001/JAMA.29
2.10.1227
Stone, J., & House, M. (2023). Measurement of cervical
softness before cerclage placement with an aspiration-
based device. American Journal of Obstetrics &
Gynecology MFM, 5, 100881. https://doi.org/10.1016/
j.ajogmf.2023.100881
Thai, Y. C., Sim, D., McCaffrey, T. A., Ramadas, A.,
Malini, H., & Watterson, J. L. (2023). A scoping review
of digital workplace wellness interventions in low- and
middle-income countries. PLOS ONE, 18(2),
e0282118. https://doi.org/10.1371/JOURNAL.PONE.0
282118
Vasudevan, S., Saha, A., Tarver, M. E., & Patel, B. (2022).
Digital biomarkers: Convergence of digital health
technologies and biomarkers. Npj Digital Medicine
2022 5:1, 5(1), 1–3. https://doi.org/10.1038/s41746-
022-00583-z
Wang, C., Lee, C., & Shin, H. (2023). Digital therapeutics
from bench to bedside. Npj Digital Medicine 2023 6:1,
6(1), 1–10. https://doi.org/10.1038/s41746-023-00777-
z
Harmonizing Innovation and Regulation: Swiss Health Insurance Navigates Digital Health Technologies for Enhanced Patient Engagement
837